Jennifer Marlowe - Dec 2, 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role: CSO, FA & Cardiac
Signature: /s/ David Tyronne Howton as attorney-in-fact for Jennifer Marlowe
Stock symbol: SLDB
Transactions as of: Dec 2, 2022
Transactions value $: $0
Form type: 4
Date filed: 12/5/2022, 04:53 PM
Next filing: Dec 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SLDB	Stock Option (Right to Buy)	Award	$0	+95.1K		$0.00	95.1K	Dec 2, 2022	Common Stock	95.1K	$6.77	Direct	F1
transaction	SLDB	Restricted Stock Units	Award	$0	+47.6K		$0.00	47.6K	Dec 2, 2022	Common Stock	47.6K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on December 2, 2022 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares on the first day of each calendar month thereafter until the fourth such anniversary.
F2	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").
F3	The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.